79 related articles for article (PubMed ID: 8917199)
21. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
22. TIPS reduces hepatic asialoglycoprotein receptor concentration in healthy pigs.
Stein M; Vera DR; Stadalnik RC
J Vasc Interv Radiol; 2000 Jan; 11(1):123-8. PubMed ID: 10693724
[TBL] [Abstract][Full Text] [Related]
23. Asialoglycoprotein receptor scintigraphy in evaluation of auxiliary partial orthotopic liver transplantation.
Sakahara H; Kiuchi T; Nishizawa S; Saga T; Nakamoto Y; Sato N; Higashi T; Tanaka K; Konishi J
J Nucl Med; 1999 Sep; 40(9):1463-7. PubMed ID: 10492366
[TBL] [Abstract][Full Text] [Related]
24. [Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand Tc-99m-galactosyl-neoglycoalbumin--preclinical and clinical studies].
Kudo M; Todo A; Ikekubo K; Hino M; Ito H; Yamaguchi H; Saiki Y; Yamamoto K; Yonekura Y; Torizuka K
Kaku Igaku; 1987 Nov; 24(11):1653-62. PubMed ID: 3446908
[No Abstract] [Full Text] [Related]
25. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
26. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Stadalnik RC; Kudo M; Eckelman WC; Vera DR
Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
[No Abstract] [Full Text] [Related]
27. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
29. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
[TBL] [Abstract][Full Text] [Related]
30. 99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro.
Virgolini I; Angelberger P; Müller C; O'Grady J; Sinzinger H
Br J Clin Pharmacol; 1990 Feb; 29(2):207-14. PubMed ID: 2306412
[TBL] [Abstract][Full Text] [Related]
31. [Characterization of receptor-mediated binding of 99mTc-NGA in vitro].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):22-5. PubMed ID: 8070765
[TBL] [Abstract][Full Text] [Related]
32. [Preparation of galactosyl-cytochrome C and studies on its hepatic targeting property].
Zhong Y; Zou Y; Guan C; Jin C
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Jun; 27(2):130-3. PubMed ID: 9389025
[TBL] [Abstract][Full Text] [Related]
33. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
[TBL] [Abstract][Full Text] [Related]
34. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
35. Asialoglycoproteins as radiodiagnostic agents for detection of hepatic masses and evaluation of liver function.
Makdisi WF; Versland MR
Targeted Diagn Ther; 1991; 4():151-62. PubMed ID: 1665718
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
37. Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.
Virgolini I; Kornek G; Höbart J; Li SR; Raolerer M; Bergmann H; Scheithauer W; Pantev T; Angelberger P; Sinzinger H
Br J Cancer; 1993 Sep; 68(3):549-54. PubMed ID: 8353045
[TBL] [Abstract][Full Text] [Related]
38. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin.
Tanaka A; Shinohara H; Hatano E; Sato S; Kanazawa A; Yamaoka Y; Torizuka T; Konishi J; Tamaki N
Hepatogastroenterology; 1999; 46(25):369-75. PubMed ID: 10228824
[TBL] [Abstract][Full Text] [Related]
39. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Woodle ES; Ward RE; Stadalnik RC; Vera DR
Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetic studies on 99mTc-NGA in human].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
